SCHEMBL9103842

SCHEMBL9103842

CC(C)[C@@H](CN1CCCC1)N(C)C(=O)c1cc(F)c(F)c(F)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9103849 1.00 — —
SCHEMBL9100052 0.88 — —
SCHEMBL9100060 0.88 — —
SCHEMBL9102642 0.84 CHRM2 (0.38) —
SCHEMBL9101350 0.84 CHRM2 (0.38) —
SCHEMBL9101341 0.84 CHRM2 (0.38) —
SCHEMBL9102660 0.84 CES2 (0.38) —
SCHEMBL9102650 0.84 CES2 (0.38) —
SCHEMBL9105374 0.83 CHRM2 (0.40) —
SCHEMBL9105364 0.83 CHRM2 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025082731-A1 INTRANASAL FORMULATIONS FOR TREATING OBSTRUCTIVE SLEEP APNEA MOSANNA THERAPEUTICS AG (CH) 2025-04-24 — — WO disclosed
US-20130143858-A1 COMPOUNDS AND THEIR USE AS IKACH BLOCKERS ASTRAZENECA AB (SE) 2013-06-06 — — US disclosed
US-8361998-B2 Compounds and their use as IKACh blockers ASTRAZENECA AB 2013-01-29 — — US disclosed
WO-2012074469-A1 NEW IKACH BLOCKERS ASTRAZENECA AB (SE) 2012-06-07 — — WO disclosed
US-20120142659-A1 COMPOUNDS AND THEIR USE AS IKACH BLOCKERS ASTRAZENECA AB (SE) 2012-06-07 — — US disclosed
Send feedback